BRCA1 or BRCA2 is a screening test for hereditary breast ovarian cancer syndrome (HBOC syndrome). It is used for screening in patient with family history of HBOC or multiple non-hereditary risk factors for breast cancer. First-tier test to assess risk for BRCA-related breast and/or ovarian cancer syndrome in Ashkenazi Jewish people with or without a family history of an ethnicity-associated mutation.
Fine needle aspiration or breast biopsy excisional can be done as an alternative,
Used if breast cancer is diagnosed and for therapy selection.
Used if breast cancer is diagnosed and for therapy selection.
Used if breast cancer is diagnosed, for therapy selection.
Monitor liver enzymes related to cancer spread. Some components of this panel might be part of comprehensive metabolic panel.
If cancer is diagnosed.
If cancer is diagnosed.
If disease management tests are elevated and if cancer spread to lymph notes is anticipated.
If indication for cancer spread to bone exists.
If cancer diagnosed to evaluate for metastatic disease.
Alternative to Comprehensive Metabolic Panel.
Supportive in hereditary breast cancer diagnosis.